**Core Concept**
Abatacept is a costimulatory signal inhibitor that modulates the immune response by blocking the interaction between CD80/CD86 on antigen-presenting cells and CD28 on T cells. This mechanism of action makes it an effective treatment for autoimmune diseases characterized by T cell activation.

**Why the Correct Answer is Right**
Abatacept is specifically used in the treatment of rheumatoid arthritis, a chronic autoimmune disorder characterized by inflammation and destruction of joints. By inhibiting the costimulatory signal, abatacept reduces T cell activation and proliferation, thereby decreasing the production of pro-inflammatory cytokines and alleviating disease symptoms. This mechanism is particularly beneficial in patients with rheumatoid arthritis who have failed to respond to other treatments.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because abatacept is not primarily used in the treatment of lupus nephritis, although it may be considered in some cases. The primary treatment for lupus nephritis involves immunosuppressive agents such as cyclophosphamide and mycophenolate mofetil.
**Option B:** This option is incorrect because abatacept is not used in the treatment of multiple sclerosis, which is typically managed with disease-modifying therapies such as interferons and natalizumab.
**Option C:** This option is incorrect because abatacept is not used in the treatment of Crohn's disease, which is typically managed with anti-TNF agents such as infliximab and adalimumab.

**Clinical Pearl / High-Yield Fact**
Abatacept is a valuable treatment option for patients with rheumatoid arthritis who have failed to respond to other disease-modifying therapies, and its mechanism of action provides a unique approach to modulating the immune response.

**Correct Answer:** C. Rheumatoid Arthritis